Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Perineuronal net components are a group of extracellular matrix macromolecules — chiefly "chondroitin sulfate proteoglycans" (aggrecan, brevican, neurocan, versican), "hyaluronan", "link proteins" (HAPLN1, HAPLN4), and "tenascin-R" — that condense around certain classes of neurons in the central nervous system to form a mesh-like structure, the perineuronal net[1][2][3][4][5][8]. These nets regulate synaptic plasticity, stabilize synapses, protect neurons from oxidative damage, and play key regulatory roles in critical period closure during development and adult CNS plasticity. Rather than a classical single drug target, the perineuronal net represents a regulatory “scaffold” whose manipulation (usually by enzymatic degradation) is an emerging therapeutic strategy in CNS repair and disease modification research.
Enzymatic degradation of chondroitin sulfate proteoglycans (e.g., ChABC increases CNS plasticity) Enzymatic degradation of hyaluronan (hyaluronidase) Modulation of ECM to promote or inhibit synaptic plasticity
2 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Perineuronal net component (PNN component).